Fujian Aonong Biological Technology Group Incorporation Ltd (603363) — Cash Flow Quality Index
Fujian Aonong Biological Technology Group Incorporation Ltd (603363) has a Cash Flow Quality Index of 0.55x as of September 2025. Operating cash flow of CN¥29.28 Million is below net income of CN¥53.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 603363 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Fujian Aonong Biological Technology Group Incorporation Ltd Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 603363 cash flow metrics.
Annual Cash Flow Quality Index for Fujian Aonong Biological Technology Group Incorporation Ltd (2014–2024)
Year-by-year earnings quality comparison for Fujian Aonong Biological Technology Group Incorporation Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.85x | CN¥-116.78 Million | CN¥63.09 Million | ▼ -553.0% |
| 2020 | 0.41x | CN¥406.02 Million | CN¥993.61 Million | ▼ -89.6% |
| 2019 | 3.93x | CN¥394.16 Million | CN¥100.36 Million | ▲ +47.6% |
| 2018 | 2.66x | CN¥27.26 Million | CN¥10.24 Million | ▲ +1113.5% |
| 2017 | 0.22x | CN¥26.78 Million | CN¥122.08 Million | ▼ -81.6% |
| 2016 | 1.19x | CN¥128.95 Million | CN¥108.35 Million | ▼ -64.4% |
| 2015 | 3.34x | CN¥129.24 Million | CN¥38.69 Million | ▲ +489.2% |
| 2014 | -0.86x | CN¥-33.66 Million | CN¥39.22 Million | — |